Exact Mass: 260.0882564
Exact Mass Matches: 260.0882564
Found 133 metabolites which its exact mass value is equals to given mass value 260.0882564,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
BENZNIDAZOLE
P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01C - Agents against leishmaniasis and trypanosomiasis > P01CA - Nitroimidazole derivatives D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D009676 - Noxae > D009153 - Mutagens
3-Furanmethanol glucoside
3-Furanmethanol glucoside is found in pulses. 3-Furanmethanol glucoside is isolated from seeds of Vigna angularis (azuki bean). Isolated from seeds of Vigna angularis (azuki bean). 3-Furanmethanol glucoside is found in pulses.
1,2,3,4-Tetrahydro-b-carboline-1,3-dicarboxylic acid
1,2,3,4-Tetrahydro-b-carboline-1,3-dicarboxylic acid is found in alcoholic beverages. 1,2,3,4-Tetrahydro-b-carboline-1,3-dicarboxylic acid is present in fruit syrups, beer, wines, vinegar and most fermented sauce
4'-Hydroxyflurbiprofen
C15H13FO3 (260.08486800000003)
4-Hydroxyflurbiprofen is a metabolite of flurbiprofen. Flurbiprofen is a member of the phenylalkanoic acid derivative family of non-steroidal anti-inflammatory drugs (NSAIDs) used to treat the inflammation and pain of arthritis. It is known by the following tradenames: Urbifen marketed by General Pharmaceuticals, Ansaid, marketed by Pfizer, Flurwood by W. Woodward and Froben, by Abbott. Flurbiprofen is also used as an active ingredient in some kinds of throat lozenges. (Wikipedia)
2'-Fluorothymidine
J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors 2'-Fluorothymidine (2'-Fluoro-2'-deoxythymidine), a bioisostere of both thymidine (TdR) and methyluridine, is a putative highly selective substrate for thymidine kinase type 2 (TK2)[1].
Uridine, 2'-deoxy-2'-fluoro-2'-methyl-, (2'R)-
Benznidazole
P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01C - Agents against leishmaniasis and trypanosomiasis > P01CA - Nitroimidazole derivatives D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D009676 - Noxae > D009153 - Mutagens
Fluorothymidine
Furafylline
D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065609 - Cytochrome P-450 CYP1A2 Inhibitors C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-5-methyl-1,2-oxazole-3-carboxamide
(1Z,3Z,9Z)-1-Chlorohexadeca-5,7-diyne-1,3,9-trien-15-one
2-methylene-3-methoxy-2,5-dihydrofuran-4-O-beta-D-glucopyranoside
3,6-dihydroxy-7-methoxycarbonyl-octahydrocyclopenta[c]pyran-4-carboxylic acid
(Z)-2-(1H-indol-3-ylmethylidene)-1,2-dihydro-3H-indol-3-one
2-(5,6-dihydroxy-3-methoxycarbonylcyclohex-3-en-1-yl)oxypropanoic acid
1,2,3,4-Tetrahydro-b-carboline-1,3-dicarboxylic acid
3-Furancarboxamide,2-methyl-N-(4-methyl-2-nitrophenyl)-(9CI)
[3-(4-FLUORO-BENZYLOXY)-PHENYL]-ACETIC ACID
C15H13FO3 (260.08486800000003)
3-[(3-FLUOROBENZYL)OXY]-4-METHOXYBENZALDEHYDE
C15H13FO3 (260.08486800000003)
4-[(3-fluorophenyl)methoxy]-3-methoxybenzaldehyde
C15H13FO3 (260.08486800000003)
2-(3-FLUORO-BENZYLOXY)-3-METHOXY-BENZALDEHYDE
C15H13FO3 (260.08486800000003)
METHYL 6-FLUORO-4-METHOXY-[1,1-BIPHENYL]-3-CARBOXYLATE
C15H13FO3 (260.08486800000003)
METHYL 5-FLUORO-2-METHOXY-[1,1-BIPHENYL]-4-CARBOXYLATE
C15H13FO3 (260.08486800000003)
2-[[(4-cyano-1-phenylpyrazol-3-yl)amino]methylidene]propanedinitrile
2-[(2-FLUOROBENZYL)OXY]-3-METHOXYBENZALDEHYDE
C15H13FO3 (260.08486800000003)
2-[(4-FLUOROBENZYL)OXY]-3-METHOXYBENZALDEHYDE
C15H13FO3 (260.08486800000003)
ETHYL 7-AMINO[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-6-CARBOXYLATE
Clevudine
J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C471 - Enzyme Inhibitor > C29575 - DNA Polymerase Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Clevudine (L-FMAU), a nucleoside analog of the unnatural L-configuration, has potent anti-HBV activity with long half-life, low toxicity. Clevudine is a non-competitive inhibitor that is not incorporated into the viral DNA but rather binds to the polymerase. Clevudine is active against cowpox virus respiratory infection in mice[1][2][3].
PSI-6206
PSI-6206 (RO 2433) is the deaminated derivative of PSI-6130, which is a potent and selective inhibitor of HCV NS5B polymerase. PSI-6206 low potently inhibits HCV replicon with EC90 of >100 μM.
Methyl 6-acetamido-4-hydroxyquinoline-2-carboxylate
4-[(2-FLUOROBENZYL)OXY]-N-HYDROXYBENZENECARBOXIMIDAMIDE
methyl 3-amino-5-[(4-fluorophenyl)methyl]pyridine-2-carboxylate
[4-formyl-3-(4-methoxyphenyl)-1H-pyrazol-1-yl]acetic acid
5,6-dihydroxy-2-p-tolyl-pyrimidine-4-carboxylic acid methyl ester
2-methyl-1,3,4,4a,5,9b-hexahydropyrido[4,3-b]indole,dihydrochloride
2-fluoro-5-methoxy-4-phenylmethoxybenzaldehyde
C15H13FO3 (260.08486800000003)
3-(4-FLUORO-BENZYLOXY)-4-METHOXY-BENZALDEHYDE
C15H13FO3 (260.08486800000003)
1,3,5-Tri-O-acetyl-2-deoxy-D-erythro-pentofuranose
1,3,5-tri-O-Acetyl-2-deoxy-alpha-D-erythro-pentofuranose
4-[(4-fluorobenzyl)oxy]-3-methoxybenzenecarbaldehyde
C15H13FO3 (260.08486800000003)
2-(3-((3-Fluorobenzyl)oxy)phenyl)acetic acid
C15H13FO3 (260.08486800000003)
2-(4-Fluorophenyl)-1-(2-hydroxy-4-methoxyphenyl)ethanone
C15H13FO3 (260.08486800000003)
ETHYL 5-AMINO-6-OXO-1-PHENYL-1,6-DIHYDRO-1,2,4-TRIAZINE-3-CARBOXYLATE
(2S,4S,5R)-5-(ACETOXYMETHYL)TETRAHYDROFURAN-2,4-DIYL DIACETATE
Poly(2-acrylamido-2-methyl-1-propanesulfonic acid-co-acrylonitrile)
3-(4-FLUORO-PHENOXYMETHYL)-4-METHOXY-BENZALDEHYDE
C15H13FO3 (260.08486800000003)
4-[(2-fluorophenyl)methoxy]-3-methoxybenzaldehyde
C15H13FO3 (260.08486800000003)
ethyl 4-(pyridin-4-ylcarbamoyl)-1H-imidazole-5-carboxylate
(5-nitro-1-benzofuran-2-yl)-pyrrolidin-1-ylmethanone
1H-Pyrrole-2-carboxamide,N-(2-aminophenyl)-1-methyl-4-nitro-(9CI)
2,3,4,6,7,11B-HEXAHYDRO-1H-PYRAZINO[2,1-A]ISOQUINOLINE DIHYDROCHLORIDE
4-CHLORO-6-(3,4-DIHYDRO-1(2H)-QUINOLINYL)-5-PYRIMIDINAMINE
2-BENZYL-5,6-DIHYDROXY-PYRIMIDINE-4-CARBOXYLIC ACID METHYL ESTER
(3,4-DIMETHOXYPHENYL)(4-FLUOROPHENYL)METHANONE
C15H13FO3 (260.08486800000003)
rel-(1S,4S)-2-benzyl-2,5-diazabicyclo[2.2.1]heptane;dihydrochloride
5-Methyl-2-fluoroarauracil F-18
C1446 - Radiopharmaceutical Compound > C2124 - Radioconjugate
4-(2-aminoethyl)-N,N-bis(2-chloroethyl)aniline
D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds
Uridine, 2'-deoxy-2'-fluoro-2'-methyl-, (2'R)-
1-[2-Fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione
2-[2-Oxo-2-[(2-oxoazepan-3-yl)amino]ethyl]sulanylacetic acid
4,5-dihydroindolo[3,2-c]pyrrolo[3,2,1-ij]quinolin-7(12H)-one
(4Z)-2-(1,3-benzodioxol-5-yl)-4-[(dimethylamino)methylidene]-1,3-oxazol-5(4H)-one
N-methyl-5-nitro-N-(phenylmethyl)-2-furancarboxamide
(2R,4S)-2-[(1R)-1-formamido-2-oxopropyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid
2-Hydroxy-3-methyl-1,4-naphthoquinone, TMS derivative
2-(5,6-Dihydroxy-3-methoxycarbonylcyclohex-3-en-1-yl)oxypropanoic acid
2,4-Dimethyl-4,4A-dihydro-1H-(1,3,5)triazino(1,2-A)quinazoline-1,3,6(2H,5H)-trione
2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-1,3-dicarboxylic acid
1,2,3,4-Tetrahydro-beta-carboline-1,3-dicarboxylic acid
HIF-IN-1
HIF-IN-1 (Compound 3c) is a hypoxia-inducible factor (HIF)-1 inhibitor. HIF-IN-1 suppresses HIF-1α protein accumulation without affecting the levels of HIF-1α mRNA. HIF-IN-1 shows no obvious cytotoxicity[1].
Nifenalol (hydrochloride)
C11H17ClN2O3 (260.09276420000003)
Nifenalol hydrochloride is a β-adrenergic receptor antagonist. Nifenalol hydrochloride induces the Early Afterdepolarization (EAD) effect. EAD is a phenomenon in cardiac electrophysiology that usually occurs during an action potential in ventricular muscle cells and can lead to arrhythmia. The EAD effect of Nifenalol hydrochloride can be blocked by Tetrodotoxin. Nifenalol hydrochloride is used in the study of conditions such as irregular heartbeat or high blood pressure[1].
(7z,13z,15z)-16-chlorohexadeca-7,13,15-trien-9,11-diyn-2-one
(3as,4s,5s,6ar)-4-(4-carboxybutyl)-2-hydroxy-3h,3ah,4h,6h,6ah-thieno[3,4-d]imidazol-5-ium-5-olate
4-[(2-amino-4,5-dimethylphenyl)imino]-2,6-dihydroxypyrimidin-5-one
(3as,4s,6ar)-4-(4-carboxybutyl)-2-hydroxy-3h,3ah,4h,6h,6ah-thieno[3,4-d]imidazol-5-ium-5-olate
(5s)-3-(hydroxymethyl)-4,5-dimethyl-5h,6h,7h-naphtho[2,3-b]thiophen-8-one
(7z,13e,15z)-16-chlorohexadeca-7,13,15-trien-9,11-diyn-2-one
methyl (4r,4ar,5r,6s,7s,7as)-5,6,7-trihydroxy-7-methyl-1-oxo-hexahydrocyclopenta[c]pyran-4-carboxylate
(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-[(5-methylidene-2h-furan-3-yl)oxy]oxane-3,4,5-triol
4-(4-carboxybutyl)-2-hydroxy-3h,3ah,4h,6h,6ah-thieno[3,4-d]imidazol-5-ium-5-olate
methyl 5,6,7-trihydroxy-7-methyl-1-oxo-hexahydrocyclopenta[c]pyran-4-carboxylate
5-chloro-4,6-dihydroxy-3-(3-hydroxy-3-methylbut-1-en-1-yl)-6-methylcyclohex-2-en-1-one
C12H17ClO4 (260.08153120000003)
methyl 1,5,6,7-tetrahydroxy-7-methyl-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-4-carboxylate
11-methyl-6h-pyrido[4,3-b]carbazole-5-carbaldehyde
(2r,3r,4s,5s,6r)-2-(furan-3-ylmethoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
(4r,5s,6s)-5-chloro-4,6-dihydroxy-3-[(1e)-3-hydroxy-3-methylbut-1-en-1-yl]-6-methylcyclohex-2-en-1-one
C12H17ClO4 (260.08153120000003)